The mission of the Applied, Connected, Entrepreneurial and Engaged European University (ACE2-EU) is to equip our students, staff, researchers, and external stakeholders with the knowledge, skills, and competencies needed to collectively address future challenges. Addressing these challenges, including the twin digital and green transitions and socio-economic issues, will deliver sustainable societal transformation, benefiting not only our regions and the EU, but society in general.
The strength of the Medical University of Gdańsk is its modern research and clinical infrastructure (headed by the University Clinical Centre). The university additionally establishes structures supporting science and knowledge transfer, which are a key element currently building a new quality of science at the Medical University of Gdańsk.
These structures constitute the foundation for the development of science at the Medical University of Gdańsk and are a pillar of activities undertaken by the University as part of the Excellence Initiative – Research University programme with the overarching goal of the program, which is: to improve the quality of scientific activity and the level of education quality, and consequently, raise theinternational significance of the university’s activities.
Centre of Biostatistics and Bioinformatics Analysis
The Centre of Biostatistics and Bioinformatics Analysis offers a wide range of services related to the broadly understood biostatistical and bioinformatic analysis as well as big data analysis. The activity profile includes mainly support for projects based on high-throughput DNA and RNA sequencing (including single cell analysis), as well as other scientific initiatives that require processing of large amounts of data. Additionally, the activities of the Centre will include the use of artificial intelligence in the processing of imaging data and the classification of patient samples. One of the key initiatives of the unit is the Biostatistics Clinic, offering MUG employees and doctoral students the opportunity to discuss the optimal approach to statistical data analysis. The Centre of Biostatistics and Bioinformatics Analysis will provide researchers with professional support at every stage of research, from designing the measurement methodology, through data acquisition and analysis, to the final interpretation.
As part of the Initiative of Excellence – Research University Program at the Medical University of Gdańsk, a new core facility is being created – the Bioanalytical Laboratory, whose main goal will be to cooperate with research teams of the MUG and the UCC by supporting the process of scientific research and clinical trials in the field of analytics and bioanalysis, especially in the context of Priority Areas Research (oncology, cardiology and cardiovascular medicine as well as biochemistry, genetics and molecular biology). The Centre will employ analysts and bioanalysts, whose work will strengthen the interdisciplinary nature of research, development and implementation work carried out at the MUG and will enable the implementation of the above projects by external entities.
Excellence of Scientific Publications Unit
The scientific potential of the Medical University of Gdańsk is over a thousand researchers and over three hundred doctoral students, active in publications fields in the national and international scientific circuit. The Excellence of Scientific Publications Unit was established with a view to them. As part of it, we offer comprehensive support in the field of communication of research results, in particular at various stages of preparation of scientific publications in English.
The activity of ECTC is aimed at conducting clinical research at the early stage of developing innovative therapies, especially in Priority Research Areas of the Medical University of Gdańsk, as defined in the Excellence Initiative – Research University Program. These scientific studies evaluate the safety and efficacy of therapies in numerous therapeutic areas, specifically oncology, hematology, cardiology, neurology and connective tissue diseases. Phase I/II studies at ECTC include first-in-human designs with dose escalation, drug interactions, food interactions, cardiovascular safety, close monitoring of pharmacokinetics/pharmacodynamics, among others.
Translational Brain Diseases Centre
The Translational Brain Diseases Centre of the Fahrenheit Union of Universities is another university-wide unit on the map of initiatives supported under the Excellence Initiative – Research University program. It was established to make the most of MUG’s scientific and research potential in neuroscience.
In order to achieve innovative interdisciplinary projects focused on personalised medicine, MUG has established the Translational Medicine Centre in 2019. Tasks are fulfilled in the Centre through the application of the concept of translational medicine, which is understood as the method of the fast transfer of knowledge gained in an experiment to the daily clinical practice.
Early Clinical Trials Unit (ECTU) is a structure established by MUG in 2019 with direct involvement of UCC. Because of ECTU, it is possible to complete clinical research on innovative drugs.
Clinical Research Support Centre
The objectives of establishing the CRSC in years 2021-2026 are to consolidate activities aimed at developing a path increasing the quality of clinical trials and increasing the availability of patients to new therapies and treatment regimens.
To improve the international status of its research, MUG has intensified an effort on creating Centres of Scientific Excellence in its structures. An example of this activity is the International Research Agenda (IRA) established in 2018. It is a joint intercollegiate unit of MUG and the University of Uppsala, focusing on research on genetic aberrations acquired during a lifetime as a risk factor of cancer and other diseases. This unit was established owing to funds donated by the Foundation for Polish Science within the program of the International Research Agenda (IRA).
Tri-City University Animal House – Research Service Centre
The Tri-City Academic Laboratory Animal Centre is currently one of the most modern facilities of this type in Poland and is an innovative base that allows for world-class research on animals. TAZD – CBU GUMed covers an area of 1100 m2, within which there are two separate passages behind a sanitary and hygienic barrier with 14 rooms for laboratory animals, used for breeding and keeping them, as well as for performing treatments and experimental procedures; quarantine; treatment rooms and utility facilities along with a fully automated washing room and sterilization room.
Interdepartmental Laboratory for In Vivo Research
The unit was established thanks to the initiative of one of the coordinators of Research Team V: In vivo studies on mechanism of disease and therapy in PRA 3, and represents a synergistic collaboration of experienced scientists from the Departments that make up the laboratory. Due to the interdisciplinary nature of the unit, collaboration with the In Vivo Research Laboratory allows for the planning and execution of specialized in vivo studies and analyses from different areas of experimental medicine during a single research project or preclinical trial.
The expanding collections of biological material can pose a challenge for their inventory and management. That is why we offer consulting assistance in matters of freezing mapping as well as organizing and electronic recording of the collected sample collections. An organized electronic sample register will facilitate collection management and enable quick and precise location of each sample by assigning them to a specific position in a box, rack, freezer shelf and freezer.
BioBank of the Department of Laboratory Medical Diagnostics (DLMD) at MUG is a unique structure of highly specialised laboratories with a biorepository adapted to translational research in a large scale. BioBank MUG is a strategic nodal biobank of the Consortium of Polish Biobank Network (PBN) BBMRI.PL, which operates under the patronage of the Ministry of Science and Higher Education. BBMRI.PL is a member of the European Network of Biobanks: Biobanking and BioMolecular Recourses Research Infrastructure (BBMRI-ERIC.EU) – the largest European scientific biomedical organization (European Research Infrastructure Consortium; ERIC).
The intellectual property (IP) policy of MUG focuses on creating and disseminating knowledge and the optimization of benefits from the use of intellectual rights. The essential units at the University in the process of technology transfer and commercialization of intellectual property are the Technology Transfer Office (TTO) and the special purpose company of GUMed, Centre of Medical Innovations Ltd. (CMI Ltd.).
Researchers Support Centre Office
The MUG is an efficient university relying on high organisational culture, supported by modern management methods. One of the assumptions of the “Initiative of Excellence – Research University” Program at the Medical University of Gdańsk is to increase the effectiveness of scientific research by reducing the administrative burden on researchers. The MUG’s unit implementing the assumptions of the IDUB Program in this area is the “Researchers Support Centre” Office, on the basis of which the Centre for Service Excellence will be established in the future.
The HR Strategy for Researchers (HRS4R) exists to support research institutions in implementing the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers into their daily practices and internal policies.
The European Charter for Researchers describes the rights and obligations to which researchers and the institutions that employ them are subject, while the Code of Conduct for the Recruitment of Researchers contains rules for the recruitment of researchers that employer institutions should follow to ensure equal treatment for researchers recruited in Europe.
The Medical University of Gdańsk has been awarded the HR Strategy distinction and the HR Excellence in Research symbol. The European Commission certificate was awarded on 30 August 2024.
The implementation of the principles from the Charter and Code by research institutions makes them more attractive to researchers looking for a new employer or host for their research project, and promotes units in national and international grant competitions.
Institutions that effectively implement all the principles of the Charter and the Code are awarded the HR Excellence in Research Award by the European Commission, which highlights the commitment to implementing fair and transparent procedures for recruiting and evaluating researchers.
The assumptions of the HR Strategy for Scientists are described in detail on the European Commission’s website.
The aim of the European HR strategy is, therefore, to continuously improve the employment and recruitment conditions of researchers in research centres, and institutions that effectively implement the principles of the Charter and the Code are awarded the HR Excellence in Research label by the European Commission.
Obtaining the HR Certificate is of crucial importance for the Medical University of Gdańsk. The introduction of standards related to the recruitment of researchers according to the HR Excellence for Research model will increase the prestige of the university as a scientific institution, creating the best working conditions for researchers in the implementation of research and development activities. MUG joining the distinguished institutions will have a real impact on the daily work, comfort and development of the scientific community and the improvement of working conditions at our University – explains Prof. Michał Markuszewski, Vice-Rector for Science (2020-2024), currently the Rector of the Medical University of Gdańsk, heading the project team.
As part of the implementation of Objective 4 of the Excellence Initiative – Research University Program entitled Preparation and implementation of comprehensive solutions for the professional development of the University’s staff, especially young researchers, the University wants to shape the development of researchers so that they can create valuable scientific content, have time for consultation, networking, collaboration with other researchers and celebrating successes. In addition, the implementation of activities aimed at achieving European certification is planned as one of the goals of the MUG Strategy for 2019-2025.
In addition to the certification itself, the initiatives we are undertaking include nurturing the image of a friendly employer and increasing the attractiveness of employment for both academic and administrative staff. The European Commission promotes the awarded institutions among scientists and international organisations as those that provide the best working and development conditions for rsearchers – adds Prof. M. Markuszewski.
The HR Strategy for Researchers (HRS4R) exists to support research institutions in implementing the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers into their daily practices and internal policies.
The European Charter for Researchers describes the rights and obligations to which researchers and the institutions that employ them are subject, while the Code of Conduct for the Recruitment of Researchers contains rules for the recruitment of researchers that employer institutions should follow to ensure equal treatment for researchers recruited in Europe.
Meet the HRS4R team at the Medical University of Gdańsk.
Description of actions required to obtain the HR Excellence in Research certificate.
Collection of documents related to the HR Excellence in Research initiative.
Set of internal regulations aimed at obtaining the European HR Excellence in Research certificate.
Find out what you should know about the HR Excellence in Research initiative.
(+48) 58 349 18 78
hrexcellence@gumed.edu.pl
ul. M. Skłodowskiej-Curie 3a
80-211 Gdańsk
We are pleased to invite you to the open sessions of the CODE-YAA COST Action meeting, hosted by the Department of Palliative Medicine at the Medical University of Gdańsk.
This meeting offers a unique opportunity to learn more about an international initiative focused on developing quality indicators for palliative care education. Participants will be introduced to project updates, innovative research methods, and available grant opportunities, as well as possibilities for international collaboration.
CODE-YAA is a COST Action bringing together researchers and innovators from 28 countries, dedicated to strengthening cooperation and advancing excellence in palliative care education across Europe.
To find out more, please visit the project and COST Association websites:
https://codeyaa.eu/
https://www.cost.eu/actions/CA22127/
CODE-YAA meeting will be held at the Medical University of Gdańsk, Poland, on 4 February 2026, from 9:00–10:30 AM (CET).
To join the meeting online, please click the following link https://teams.microsoft.com/meet/32149444230870?p=a6TYmntn1xfGisJkBJ
09:00 – 09:15
Welcome and Opening Remarks
Prof. Piret Paal
Prof. Monika Lichodziejewska-Niemierko
09:15 – 09:30
Palliative Care in Poland: The Gdańsk Model of Education in Palliative Medicine
Prof. Monika Lichodziejewska-Niemierko
09:30 – 09:50
CODE-YAA@PC-EDU COST Action – Objectives, Updates, and Potential Practical Implications
Prof. Piret Paal, Dr Minna Hökkä
09:50 – 10:10
Overview of the CODE-YAA@PC-EDU Project Research Findings (Main Results of the Reviews and Delphi Process)
Dr Anna Pedrosa Carrasco, Dr Stephen Mason, Dr Tania Pastrana
10:10 – 10:25
Available Grant Programmes and Funding Opportunities
Dr Leszek Pawłowski
10:25 – 10:30
Announcement of the Winner of the CODE-YAA Influencer Award
Prof. Piret Paal, Dr Minna Hökkä
The early detection of lung cancer using thoracic CT has been widely demonstrated in multiple international trials to objectively increase cure rates. Now the international focus is on effective and economical implementation. Increasingly, it is emerging that thoracic CT screening is also detecting a range of early tobacco-related diseases including cardiovascular disease and chronic obstructive pulmonary disease. These three diseases comprise the ‘BIG3’, as they collectively account for close to half of the premature deaths globally. Thoracic CT screening presents a unique opportunity to integrate care for this high risk cohort with a single imaging examination. We plan to develop optimized protocols for evaluation of these major diseases, explore challenges and define solutions in enabling implementation, especially for economically disadvantaged countries across the world. A core strategy in achieving this ambitious goal is to leverage the use of AI processes across the continuum of care, including its use for risk assessment, disease detection and managing disease interventions.
It is with our profound sorrow that we announce that on 26th January 2026, Prof. Magdalena Prokopowicz, Dean of the Faculty of Pharmacy at the Medical University of Gdańsk, has passed away. She was a highly esteemed scientist, an academic teacher of many generations of students of the Faculty of Pharmacy, and the author of numerous scientific publications.
Prof. Magdalena Prokopowicz, Pharm.D., was an academic teacher and professor of medical and health sciences in the discipline of pharmaceutical sciences. In the years 2020-2024, she served as Vice-dean for Education of the Faculty of Pharmacy, and from 2024 she held the position of the Dean of the Faculty of Pharmacy.
She obtained the degree of Master of Science in Biotechnology Engineering in 1994 from the Faculty of Chemistry at the Gdańsk University of Technology. In 1995, she commenced doctoral studies at the Department of Analytical Chemistry at the Gdańsk University of Technology under the supervision of the late Prof. Jacek Namieśnik, Honorary Doctor of the Medical University of Gdańsk. She defendedwith honors her doctoral dissertation entitled Gas standard mixtures prepared on the basis of thermal decomposition of surface compounds, obtaining the degree of Doctor of Chemical Sciences. The most significant tangible scientific achievement of this research period was granting of a patent entitled A composition for preparing a liquid standard mixture, especially for the calibration of Analytical Instruments, No. 194181, B1 (31st May 2007), Gdańsk University of Technology.
In 1999, she began her professional career at the Department of Physical Chemistry at the Medical Academy in Gdańsk. In 2012, she was awarded the habilitation degree of the Doctor of Science of Pharmaceutical Sciences, based on the scientific achievement entitled Preparation and physicochemical characterization of silica xerogels as solid carriers of doxorubicin hydrochloride – an anticancer agent. On 1st December 2021, she was appointed an Associate Professor, and from 3rd February 2023, she held the title of Professor of Medical and Health Sciences in the discipline of Pharmaceutical Sciences.
She continued her scientific research on bioactive silica gel composites in collaboration with scientists from the SFI Research Centre for Pharmaceuticals at the University of Limerick (Ireland), where she completed a scientific fellowship as a Visiting Scientist. Her work on silica gels resulted in another patent in 2020 entitled A pharmaceutical composition for bone tissue implantation, a method for its preparation, and its use in the manufacture of an implant for the treatment of bone tissue, No. 241688 (29th May), Medical University of Gdańsk. She successfully obtained research funding from external sources – she was the principal investigator, key researcher, and scientific supervisor of seven externally funded research projects (KBN, NCN). She passed on her passion for science to subsequent generations –she supervised 3 completed doctoral dissertations and over 20 master's theses.
Alongside her research work, she was deeply committed to serving the academic community and improving the quality of education. In cooperation with the Convention of Deans of Pharmaceutical Faculties, she participated in the development of a new standard of education preparing students for the profession of pharmacist. She was a member of numerous university and faculty committees. She participated in the development of the University System for Quality Assurance in Education at the Medical University of Gdańsk. She paid particular attention to students, initiating, inspiring, and supporting activities aimed at their scientific and professional development. She was a member of the Gdańsk Scientific Society and the Polish Pharmaceutical Society. For her scientific, teaching, and organisational achievements, she was repeatedly honoured with Rector’s Awards.
Her passing is a profound loss to the academic community, her colleagues and her students.
A book of condolences has been made available in the Rectorate building, on the second floor, next to the Rector’s Office. Entries may be made until 29th January 2026 (Thursday), 2:00 p.m. The Rectorate is open from 7:00 a.m. to 3:30 p.m. On 30th January 2026 (Friday), the Book of condolences will be made available at the Faculty of Pharmacy.
The funeral ceremonies will take place on 31st January 2026 (Saturday). At 12:00 noon, a holy mass will be celebrated at the Church of St. Adalbert (Trakt św. Wojciecha, Gdańsk–Święty Wojciech). The burial service will follow immediately after the mass at the parish cemetery. The holy mass will be preceded by the rosary at 11:30 a.m.
Friday, 30th January, has been declared a day of mourning at the Faculty of Pharmacy. At 8:30 a.m., a Holy Mass will be celebrated at the church of St. Andrew Bobola, located at A. Mickiewicza 11 street, in Gdańsk–Wrzeszcz (the main church).
The lecture will be delivered by Prof. Vitalii V. Makarov, Head of the Department and Clinic of Surgery No. 4 at Kharkiv National Medical University (KNMU), Ukraine.
Confirmed professional background:
During the lecture, the following topics will be discussed:
The next scientific seminar in the series …where discovery science meets clinical medicine will take place on Friday, November 28 at 12:00 in the Prof. Zdzisław Kieturakis Auditorium at the Invasive Medicine Center, University Clinical Center (UCC).
The invited speakers will be Professor Jacek Jaworski, Ph.D., D.Sc., Head of the Laboratory of Molecular and Cellular Neurobiology at the International Institute of Molecular and Cell Biology in Warsaw, and Krzysztof Basiński, Ph.D., from the Division of Quality of Life Research, Auditory Neuroscience Laboratory, Dept. of Psychology, Medical University of Gdańsk.
Prof. Jaworski will discuss the neurobiology of mTOR, a serine/threonine protein kinase that integrates extracellular signals with cellular metabolic resources to regulate anabolic and catabolic processes. Beyond its well-known role in protein synthesis, mTOR has emerged as essential for nervous system development. His talk will provide an overview of molecular functions of mTOR beyond translation control and their relevance for neuronal development and function.
Dr. Basiński will then explore predictive processing in the auditory system, presenting empirical evidence that perception involves the brain using Bayesian inference to anticipate incoming stimuli. The focus will be on the human auditory system, including recent findings from his lab highlighting the role of sound harmonicity in predictive processing.
The speakers will present two topics:
The seminar will be conducted in English. Following the presentations, attendees are invited to refreshments—an excellent opportunity to network with researchers interested in future collaboration.
The seminar series was initiated by Dr. Aleksandra Rutkowska from the Department of Anatomy and Neurobiology, and the host of the event is Prof. Krzysztof Narkiewicz, Head of the Department of Hypertension and Diabetology at the Medical University of Gdańsk.
